ATMPs/C&GT Projects and Science: Panel Discussion and Q&A

Speaker(s):

• Laura-Ann S. Chin, BSc, MSc, PE, Director, Life Sciences, Barry-Wehmiller Design Group
• Richard Denk, Senior Consultant Aseptic Processing & Containment, SKAN AG
• Ian Gaudet, PhD, Senior Director and Site Head, San Jose Cell Manufacturing Facility, Miltenyi Biotec
• Jordan N. Hjelmquist, Program Manager - Commercial Gene Therapy, Pfizer
• Evan Lamb, Product Specialist, ATMP Applications, Skan US
• Jeffery N. Odum, CPIP, Practice Leader: ATMPs & Biologics, Genesis AEC
• Robert F. Flynn, Principal Engineer, Genzyme A Sanofi Company
• Kevin Baughman, Director of Consulting Services, Aizon
• Christian Lavarreda, Global Product Manager, Syntegon Technology
• Kimberley Buytaert-Hoefen, PhD, Executive Director and Global Head of Regulatory Affairs, QPS LLC
• Lars Waldmann, PhD, Staff Engineer, Viral Vector Services, Thermo Fisher Scientific
• Ms. Dena A. Flamm, Business Development Manager, OPTIMA Pharma